CD8A and neoplasm: The results of our study showed that AHCC® enhanced the tumor suppressive effect of DICB as well as cytotoxic molecule expression and proliferative capacity of T cells, especially tumor infiltrating CD8+ T cells, in MC38 tumor-bearing mice through possibly affecting the gut microbiota.